Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23587031)

1.

Cell-associated HIV RNA: a dynamic biomarker of viral persistence.

Pasternak AO, Lukashov VV, Berkhout B.

Retrovirology. 2013 Apr 15;10:41. doi: 10.1186/1742-4690-10-41. Review.

2.

Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.

Furtado MR, Callaway DS, Phair JP, Kunstman KJ, Stanton JL, Macken CA, Perelson AS, Wolinsky SM.

N Engl J Med. 1999 May 27;340(21):1614-22.

3.

Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients.

Burgard M, Boufassa F, Viard JP, Garrigue I, Ruffault A, Izopet J, Vabret A, Descamps D, Colson P, Seigneurin JM, Rouzioux C; ANRS AC11 Working Group.

AIDS. 2009 Oct 23;23(16):2165-71. doi: 10.1097/QAD.0b013e32833032d4.

PMID:
19657270
4.

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.

Marcelin AG, Tubiana R, Lambert-Niclot S, Lefebvre G, Dominguez S, Bonmarchand M, Vauthier-Brouzes D, Marguet F, Mousset-Simeon N, Peytavin G, Poirot C.

AIDS. 2008 Aug 20;22(13):1677-9. doi: 10.1097/QAD.0b013e32830abdc8.

PMID:
18670231
5.

Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection.

Yerly S, Perneger TV, Vora S, Hirschel B, Perrin L.

AIDS. 2000 Dec 22;14(18):2805-12.

PMID:
11153661
6.

Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome.

Pasternak AO, Jurriaans S, Bakker M, Prins JM, Berkhout B, Lukashov VV.

PLoS One. 2009 Dec 31;4(12):e8490. doi: 10.1371/journal.pone.0008490.

7.

Early Antiretroviral Therapy in South African Children Reduces HIV-1-Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells.

van Zyl GU, Bedison MA, van Rensburg AJ, Laughton B, Cotton MF, Mellors JW.

J Infect Dis. 2015 Jul 1;212(1):39-43. doi: 10.1093/infdis/jiu827. Epub 2014 Dec 23.

PMID:
25538273
8.

Antiretroviral therapy for HIV-2 infected patients.

Smith NA, Shaw T, Berry N, Vella C, Okorafor L, Taylor D, Ainsworth J, Choudhury A, Daniels RS, El-Gadi S, Fakoya A, Moyle G, Oxford J, Tedder R, O'Shea S, de Ruiter A, Breuer J.

J Infect. 2001 Feb;42(2):126-33.

PMID:
11531319
9.

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.

Alatrakchi N, Duvivier C, Costagliola D, Samri A, Marcelin AG, Kamkamidze G, Astriti M, Agher R, Calvez V, Autran B, Katlama C.

AIDS. 2005 Jan 3;19(1):25-33.

PMID:
15627030
10.

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey.

Lambert-Niclot S, Tubiana R, Beaudoux C, Lefebvre G, Caby F, Bonmarchand M, Naouri M, Schubert B, Dommergues M, Calvez V, Flandre P, Poirot C, Marcelin AG.

AIDS. 2012 May 15;26(8):971-5. doi: 10.1097/QAD.0b013e328352ae09.

PMID:
22382146
11.

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.

Ghosn J, Pellegrin I, Goujard C, Deveau C, Viard JP, Galimand J, Harzic M, Tamalet C, Meyer L, Rouzioux C, Chaix ML; French PRIMO Cohort Study Group (ANRS CO 06).

AIDS. 2006 Jan 9;20(2):159-70.

PMID:
16511408
12.

Level of human immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy.

McDermott JL, Giri AA, Martini I, Bono M, Giacomini M, Campelli A, Tagliaferro L, Cara A, Varnier OE.

J Clin Microbiol. 1999 Jul;37(7):2361-5.

13.
14.

Prognostic value of peripheral blood mononuclear cell-associated HIV-1 DNA for virological outcome in asymptomatic HIV-1 chronic infection.

Rodríguez-Sáinz C, Ramos R, Valor L, López F, Santamaría B, Hernández DC, Cruz JS, Navarro J, Modrego J, Alecsandru D, Fernández-Cruz E.

J Clin Virol. 2010 Jul;48(3):168-72. doi: 10.1016/j.jcv.2010.03.020. Epub 2010 Apr 18.

PMID:
20399705
15.

HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.

Chun TW, Fauci AS.

AIDS. 2012 Jun 19;26(10):1261-8. doi: 10.1097/QAD.0b013e328353f3f1. Review.

PMID:
22472858
16.

Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia.

Seclén E, Del Mar González M, De Mendoza C, Soriano V, Poveda E.

J Antimicrob Chemother. 2010 Jul;65(7):1493-6. doi: 10.1093/jac/dkq156. Epub 2010 May 20.

17.
19.

Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection.

Chamberland A, Sylla M, Boulassel MR, Baril JG, Côté P, Thomas R, Trottier B, Rouleau D, Routy JP, Tremblay C; Investigators of the Primary HIV-Infection Cohort of Montreal.

Int J STD AIDS. 2011 Mar;22(3):146-50. doi: 10.1258/ijsa.2010.010292.

PMID:
21464451
20.

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.

Kappes JC, Saag MS, Shaw GM, Hahn BH, Chopra P, Chen S, Emini EA, McFarland R, Yang LC, Piatak M Jr, et al.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):139-49.

PMID:
7552477
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk